Chargement en cours...
Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
The coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2, has recently emerged worldwide. In this context, there is an urgent need to identify safe and effective therapeutic strategies for treatment of such highly contagious disease. We recent...
Enregistré dans:
| Publié dans: | Microb Drug Resist |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mary Ann Liebert, Inc., publishers
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7987362/ https://ncbi.nlm.nih.gov/pubmed/33729874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/mdr.2020.0232 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|